CSL Limited share price rises 2% on ASX — what to know ahead of Feb 11 results
CSL shares rose 2.0% to A$181.70 on Wednesday, outperforming a flat health care sector as the ASX 200 gained 0.8%. Investors await CSL’s half-year results and interim dividend announcement on Feb. 11. The Reserve Bank of Australia raised rates to 3.85% this week, with another hike expected in May. CSL last cut its FY26 forecasts in October, citing weaker U.S. flu vaccination rates.